Trials / Completed
CompletedNCT02382367
Prevalence of Alpha-1 Antitrypsin Dysfunction in Pulmonary Emphysema
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 190 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this trial is to evaluate the prevalence of alpha-1 antitrypsin quantitative and functional deficiency in an adult French population presenting with pulmonary emphysema. Phenotypic and genotypic studies will be carried whenever quantitative and/or functional deficiency will be displayed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood sampling | Blood tests (Alpha-1 antitrypsin protein measurement, elastase-inhibitory capacity of plasma measurement, phenotypic and genotypic studies) |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2015-03-06
- Last updated
- 2015-12-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02382367. Inclusion in this directory is not an endorsement.